Dr. Juan Camilo Arjona Ferreira - 29 Mar 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role: Head of R&D & CMO
Signature: /s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Issuer symbol: OGN
Transactions as of: 29 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 16 Apr 2024, 06:23:35 UTC
Previous filing: 11 Jan 2024
Next filing: 12 Aug 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Award	$0	+26,595		$0.000000	26,595	29 Mar 2024	Common Stock	26,595	$0.000000	Direct	F1, F2
transaction	OGN	Stock Option (right to buy)	Award	$0	+108,932		$0.000000	108,932	29 Mar 2024	Common Stock	108,932	$18.80	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2	These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
F3	The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.